Back
Citigroup, Inc. Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison
Buy
78
C
Citigroup, Inc.
Last Price:
$111.35
Seasonality Move:
2.27%
Buy
64
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$87.20
Seasonality Move:
-30.03%
Buy
78
Citigroup, Inc. (C)
is a Buy
Is Citigroup, Inc. a Buy, Sell or Hold?
-
The current Citigroup, Inc. [C] share price is $111.28. The Score for C is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
-
C is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Bright Minds Biosciences, Inc. (DRUG)
is a Buy
Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?
-
The current Bright Minds Biosciences, Inc. [DRUG] share price is $93.99. The Score for DRUG is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
DRUG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
C Stock Price Chart
What is Citigroup, Inc.'s stock price today?
-
The Citigroup, Inc. share price today is $111.28Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and C is experiencing slight selling pressure.
DRUG Stock Price Chart
What is Bright Minds Biosciences, Inc.'s stock price today?
-
The Bright Minds Biosciences, Inc. share price today is $93.99Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.
C Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.16 | Buy |
| Relative Strength Index (14 RSI): | 69.5 | Buy |
| Chaikin Money Flow: | -6011646 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (99.45 - 109.39) | Buy |
| Bollinger Bands (100): | (94.41 - 104.09) | Buy |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.78 | Buy |
| Relative Strength Index (14 RSI): | 76.13 | Buy |
| Chaikin Money Flow: | 147064 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
C Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 110.74 | Buy |
| 20-day SMA: | 105.39 | Buy |
| 50-day SMA: | 101.67 | Buy |
| 200-day SMA: | 87.23 | Buy |
| 8-day EMA: | 110.34 | Buy |
| 20-day EMA: | 106.97 | Buy |
| 50-day EMA: | 103 | Buy |
| 200-day EMA: | 90.7 | Buy |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 84.53 | Buy |
| 20-day SMA: | 72.88 | Buy |
| 50-day SMA: | 64.83 | Buy |
| 200-day SMA: | 42.54 | Buy |
| 8-day EMA: | 84.37 | Buy |
| 20-day EMA: | 75.93 | Buy |
| 50-day EMA: | 66.06 | Buy |
| 200-day EMA: | 46.89 | Buy |
Citigroup, Inc. Earnings Growth & C Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.76 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.95 per share, and an increase next year of $1.90 per share.
Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.
Citigroup, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||